Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-γ
- 1 September 1993
- journal article
- Published by Springer Nature in Biotherapy
- Vol. 6 (3) , 189-194
- https://doi.org/10.1007/bf01878080
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Factor analysis of false-negative second-look laparotomyGynecologic Oncology, 1990
- Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after. Second-look laparotomyCancer, 1989
- Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran(SPG).Journal of Pharmacobio-Dynamics, 1989
- Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinomaGynecologic Oncology, 1988
- The Basis for the Immunoregulatory Role of Macrophages and Other Accessory CellsScience, 1987
- Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer: A randomized controlled studyCancer, 1986
- Second-look laparotomy in managing epithelial ovarian carcinomaCancer, 1986
- A review of second-look laparotomy for ovarian cancerGynecologic Oncology, 1986
- Interferon-γ is required in activation of macrophages for tumor cytotoxicityCellular Immunology, 1983
- Second-look operations in the planned management of advanced ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1982